NEW FDA APPROVED DRUGS FOR THE TREATMENT FOR ATOPIC DERMATITIS

Journal Title: World Journal of Pharmaceutical and life sciences - Year 2018, Vol 4, Issue 4

Abstract

Atopic Dermatitis (AD) is a highly pruritic chronic inflammatory skin disease that commonly presents during early childhood. It is a special form of eczematous dermatitis with wide range of severity. Several studies indicate that the disease is very common in western world with lifetime prevalence in children of 10% to 20%. In most patients it occurs before 5 yrs and typically clears by adolescence. AD has an immunologic basis. Both innate and adaptive immune responses are impaired in AD patients. Intense pruritis is a hallmark of the disease which leads to extensive scratching and further breakdown of the skin barrier. Treatment of atopic eczema should be based on a “stepped-care plan” where treatments are stepped up or down depending on the assessment of the state of the child’s skin by the physician. Both topical and systemic treatments are given for eczema. Topical corticosteroids and calcineurin inhibitors are used as topical anti-inflammatory agents. Patients should be carefully instructed about the use of topical glucocorticoids to avoid side effects. Newer drugs used in treatment of AD are Crisaborole ointment and Dupilumab injection. FDA approved these drugs on 14th December 2016 and 28th March 2017 respectively.

Authors and Affiliations

Saerah Simon

Keywords

Related Articles

ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND DETERMINATION OF ARTESUNATE IN PHARMACEUTICAL TABLET FORMULATIONS

Resistance to conventional antimalarials triggered off new policies to circumvent the devastating consequences of malaria especially in the trans-Saharan Africa. The use of artemisinin-based combinations as first line dr...

EVALUATION OF EFFECTIVENESS OF TAGETES ERECTA EXTRACT IN CONTROLLING CITRUS NEMATODE TYLENCHULUS SEMIPENETRANS IN WASIT PROVINCE

The study has been conducted in the laboratory of college of science – university of wasit in cooperation with the ministry of science and technology- directorate of agriculture research to evaluate the effect plant extr...

EFFECT OF LAND PREPARATION METHODS AND ANIMAL MANURE APPLICATION RATES ON SOIL MOISTURE CONSERVATION AND YIELD OF ONION (Allium cepa) AT GODE, SOMALI REGIONAL STATE, ETHIOPIA.

The Ethiopian economy is mainly agrarian. It employs 85% of the population and contributes 45% of the gross domestic product and 90% of the national export earnings but agriculture in Ethiopia is dominated by rainfed far...

OPTIMIZATION STUDIES ON THE PRODUCTION AND ACTIVITY OF XYLANASE OBTAINED FROM PAENIBACILLUS LAUTUS ISOLATED FROM MANGROVE SOIL

Xylanases (endo-1,4-xylanase, EC 3.2.1.8) are hydrolytic enzymes which cleaves the β-1,4- backbone of the complex plant cell wall polysaccharide, xylan which in turn releases xylooligosaccharides and xylose. The screenin...

ANTIMICROBIAL AND ANTIPROLIFERATIVE, PRO-APOPTOTIC ACTIONS OF KOMBUCHA FERMENTED SOLUTIONS AGAINST COLON AND HEPTAO CANCER CELL LINES

Introduction: Kombucha fermented solutions (KFSs) were produced from tea (KTFS), rice (KRFS) and barely (KBFS) after 8 and 10 days. These solutions tested as antimicrobial activity against microorganisms (Listeria monocy...

Download PDF file
  • EP ID EP655554
  • DOI -
  • Views 151
  • Downloads 0

How To Cite

Saerah Simon (2018). NEW FDA APPROVED DRUGS FOR THE TREATMENT FOR ATOPIC DERMATITIS. World Journal of Pharmaceutical and life sciences, 4(4), 114-121. https://www.europub.co.uk/articles/-A-655554